Anti-atherosclerotic effect of a Chinese medicine, Huanglian Jiedu Decoction, mediated by regulatory T cells
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [14]
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Objective To study the effect of a Chinese medicine, Huanglian Jiedu Decoction (HLJDD), on atherosclerotic plaque, inflammatory factors and regulatory T cells in ApoE-/- mice. Methods High fat diet was given to ApoE-/- mice to establish an atherosclerosis model. 40 male ApoE-/- mice were randomly divided into five groups:model group, simvastatin group, low, moderate and high dose HLJDD groups (n=8). HLJDD was intragastrically administered in a dose of 3.5, 7.0, or 14.0 g/(kg·bw) once dailg for 16 weeks. The dose of simvastatin was 5.0 g/(kg·bw). Another 8 male C57BL/6J mice were taken as control group. At the end of the 29-week experiment, all of the mice were sacrificed. The aortic plaques, level of blood lipids, inflammatory factors, Tregs number and the level of Foxp3 mRNA were detected and analyzed by ELISA, flow cytometry and RT-PCR, respectively. Results Compared with the control group, the aortic plaques were much larger in the model group, and the levels of TC, TG, LDL-C, IL-6, hs-CRP, and TNF-α were significantly higher than those in the control group (P < 0.01 for all). Meanwhile, the levels of HDL-C, IL-10, TGF-β and Foxp3 mRNA were much lower than those in the control group (P < 0.01 for all), and the Tregs numbers were less than that in the control group (P < 0.01). HLJDD regulated the blood lipids in ApoE-/- mice and decreased the levels of IL-6, hs-CRP, andTNF-α, however increased the levels of IL-10, TGF-β and Foxp3 mRNA. At the same time, it increased Tregs number in the ApoE-/- mice. Compared with the model group, the difference was statistically significancet (P < 0.01). Conclusions HLJDD can significantly alleviate the aortic plaque damages in ApoE-/- mice.It may be related to the up-regulation of Tregs, which can lead to decrease the expression of serum pro-inflammatory factors such like IL-10, hs-CRP and TNF-α.

    Reference
    [1] Mor A, Planer D, Luboshits G, et al. Role of naturally occurring CD4+CD25+ regulatory T cells in experimental atherosclerosis[J]. Arterioscler Thromb Vase Biol, 2007, 27:893-900.
    [2] 魏玉芬. 黄连解毒汤对CLP诱导的脓毒症大鼠的保护作用及其代谢组学研究[D]. 第二军医大学博士学位论文,2014.
    [3] Usman A, Ribatti D, Sadat U, et al. From lipid retention to immune-mediate inflammation and associated angiogenesis in the pathogenesis of atherosclerosis[J]. J Atheroscler Thromb, 2015, 22(8):739-749.
    [4] de Boer OJ, van der Wal AC. FOXP3+ regulatory T cells in vulnerable atherosclerotic plagues[J]. Int J Cardiol, 2010, 145:183-187.
    [5] de Boer OJ, van der Meer JJ, Teeling R, et al. Low numbers of F0XP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions[J]. PloS One, 2007, 2(8):e779.
    [6] Zhu ZF, Meng K, Zhong YC, et al. Impaired Circulating CD4(+)LAP(+) regulatory T cells in patients with acute coronary syndrome and its mechanistic study[J]. PLoS One, 2014, 9(2):e88775.
    [7] Feng J, Zhang Z, Kong W, et al. Regulatory T cells ameliorate hyperhomocysteinaemia accelerated atherosclerosis in apoE-/- mice[J]. Cardiov Res, 2009, 84:155-163.
    [8] Goronzy JJ, Weyand CM. Immunosuppression in atherosclerosis:mobilizing the opposition within[J]. Circulation, 2006, 114:1901-1904.
    [9] Ross R. Atherosclerosis-an inflammatory disease[J]. N Engl J Med, 1999, 340:115-126.
    [10] Kvakan H, Kleinewietfeld M, Qadri F, et al. Regulatory T cells ameliorate angiotensin Ⅱ induced cardiac damage[J]. Circulation, 2009, 119:2904-2912.
    [11] Ait-Oufella H, Wang Y, Herbin O, et al. Natural regulatory T cells limit angiotensin Ⅱ-induced aneurysm formation and rupture in mice[J]. Arterioscler Thromb Vasc Biol, 2013, 33(10):2374-2379.
    [12] Dietel B, Cicha I, Voskens CJ, et al. Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells[J]. Atherosclerosis. 2013, 230(1):92-99.
    [13] Ogawa C, Tone Y, Tsuda M, et al. TGF-β-mediated Foxp3 gene expression is cooperatively regulated by Stat5, Creb, and AP-1 through CNS2[J]. J Immunol, 2014, 192(1):475-483.
    [14] Li D, Liu Y, Chen J, et al. Suppression of atherogenesis by delivery of TGFbetal ACT using adeno-associated virus type 2 in LDLR knockout mice[J]. Biochem Biophys Res Commun, 2006, 344:701-707.
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:1555
  • PDF: 1366
  • HTML: 0
  • Cited by: 0
History
  • Received:December 08,2015
  • Online: July 01,2016
Article QR Code